Tapering immunosuppression in recipients of living donor kidney transplants

We have previously suggested that the in vitro donor-specific cytotoxic T-lymphocyte precursor (CTLp) assay can guide us to identify patients in which the immunosuppressive load can be tapered. In a clinical trial we had observed that a low (

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2004-07, Vol.19 (suppl-4), p.iv61-iv63
Main Authors: Weimar, Willem, Rischen-Vos, Jacqueline, de Kuiper, Petronella, Smak Gregoor, Peter J. H., IJzermans, Jan N. M., van Besouw, Nicole M., Baan, Carla C., van der Mast, Barbara J.
Format: Article
Language:English
Subjects:
Cells, Cultured
cytotoxic T lymphocytes
Down-Regulation - physiology
Humans
immunosuppression
Immunosuppressive Agents - administration & dosage
kidney transplantation
Kidney Transplantation - immunology
Kidney Transplantation - methods
Living Donors
Prospective Studies
T-Lymphocytes, Cytotoxic - immunology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have previously suggested that the in vitro donor-specific cytotoxic T-lymphocyte precursor (CTLp) assay can guide us to identify patients in which the immunosuppressive load can be tapered. In a clinical trial we had observed that a low (
ISSN:0931-0509
1460-2385
1460-2385
DOI:10.1093/ndt/gfh1044